ARNALDO VILLAFRANCA
Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism DAVIE, FL NPI 1497074967
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism FL Lilly USA, LLC All categories
General Payments — all program years on this page
$14,053.29
- Category: General Payments
- Program years: PY2018–2024
- Record count: 615
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,902.30 across 84 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,902.30 | 84 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $303.30 | 14 |
| Amgen Inc. | $190.61 | 11 |
| Insulet Corporation | $152.34 | 6 |
| Novo Nordisk AS | $141.92 | 7 |
| MannKind Corporation | $141.43 | 6 |
| Corcept Therapeutics | $118.60 | 5 |
| SANOFI-AVENTIS U.S. LLC | $105.75 | 4 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $99.45 | 4 |
| Tandem Diabetes Care, Inc. | $91.65 | 3 |
| Xeris Pharmaceuticals, Inc. | $85.20 | 4 |
| Abbott Laboratories | $83.14 | 4 |
| Amneal Pharmaceuticals LLC | $75.55 | 4 |
| CeQur Corporation | $62.07 | 1 |
| Verity Pharmaceuticals Inc. | $50.68 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $46.41 | 2 |
| BETA BIONICS, INC. | $43.74 | 2 |
| Antares Pharma, Inc. | $29.20 | 1 |
| IBSA Pharma Inc. | $23.08 | 1 |
| Amphastar Pharmaceuticals, Inc. | $20.75 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $19.99 | 1 |
| Acella Pharmaceuticals, LLC | $17.44 | 1 |
By program year
Records — PY2024 (84)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.